WallStreetZenWallStreetZen

NASDAQ: ETNB
89bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ETNB

Based on 5 analysts offering 12 month price targets for 89bio Inc

Min Forecast
$21.00+246.53%
Avg Forecast
$32.40+434.65%
Max Forecast
$49.00+708.58%

Should I buy or sell ETNB stock?

Based on 5 analysts offering ratings for 89bio Inc.

Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ETNB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ETNB as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their ETNB stock forecasts and price targets.

ETNB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-14
lockedlocked$00.00+00.00%2025-03-13
lockedlocked$00.00+00.00%2025-02-28
lockedlocked$00.00+00.00%2025-01-31Find Out Why
lockedlocked$00.00+00.00%2025-01-02
Raymond James
Top 15%
86
Strong BuyMaintains$49.00+708.58%2024-11-08

1 of 1

Forecast return on equity

Is ETNB forecast to generate an efficient return?

Company
-27.56%
Industry
147.71%
Market
81.76%
ETNB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ETNB forecast to generate an efficient return on assets?

Company
-23.08%
Industry
35.52%
ETNB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ETNB earnings per share forecast

What is ETNB's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.98
Avg 2 year Forecast
-$2.15
Avg 3 year Forecast
-$1.98

ETNB revenue forecast

What is ETNB's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$15.3M
Avg 2 year Forecast
$40.7M
Avg 3 year Forecast
$268.2M

ETNB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ETNB$6.06$32.40+434.65%Strong Buy
WVE$5.92$23.83+302.58%Strong Buy
DYN$8.17$44.00+438.56%Buy
RCUS$7.88$23.75+201.40%Strong Buy
GYRE$8.88N/AN/A
View Top Biotech Stocks

89bio Stock Forecast FAQ

Is 89bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ETNB) stock is to Strong Buy ETNB stock.

Out of 5 analysts, 4 (80%) are recommending ETNB as a Strong Buy, 1 (20%) are recommending ETNB as a Buy, 0 (0%) are recommending ETNB as a Hold, 0 (0%) are recommending ETNB as a Sell, and 0 (0%) are recommending ETNB as a Strong Sell.

If you're new to stock investing, here's how to buy 89bio stock.

What is ETNB's earnings growth forecast for 2025-2027?

(NASDAQ: ETNB) 89bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.2%.

89bio's earnings in 2025 is -$367,079,000.On average, 5 Wall Street analysts forecast ETNB's earnings for 2025 to be -$289,340,649, with the lowest ETNB earnings forecast at -$340,143,144, and the highest ETNB earnings forecast at -$232,114,849. On average, 4 Wall Street analysts forecast ETNB's earnings for 2026 to be -$313,865,991, with the lowest ETNB earnings forecast at -$364,960,455, and the highest ETNB earnings forecast at -$261,311,686.

In 2027, ETNB is forecast to generate -$288,566,933 in earnings, with the lowest earnings forecast at -$401,456,501 and the highest earnings forecast at -$207,297,538.

What is ETNB's revenue growth forecast for 2026-2028?

(NASDAQ: ETNB) 89bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.

89bio's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast ETNB's revenue for 2026 to be $2,235,747,747, with the lowest ETNB revenue forecast at $1,105,100,258, and the highest ETNB revenue forecast at $3,366,395,237. On average, 2 Wall Street analysts forecast ETNB's revenue for 2027 to be $5,940,096,366, with the lowest ETNB revenue forecast at $1,413,126,882, and the highest ETNB revenue forecast at $10,467,065,849.

In 2028, ETNB is forecast to generate $39,159,234,932 in revenue, with the lowest revenue forecast at $10,906,478,237 and the highest revenue forecast at $74,656,310,675.

What is ETNB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ETNB) forecast ROA is -23.08%, which is lower than the forecast US Biotechnology industry average of 35.52%.

What is ETNB's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ETNB price target, the average ETNB price target is $32.40, with the highest ETNB stock price forecast at $49.00 and the lowest ETNB stock price forecast at $21.00.

On average, Wall Street analysts predict that 89bio's share price could reach $32.40 by Mar 13, 2026. The average 89bio stock price prediction forecasts a potential upside of 434.65% from the current ETNB share price of $6.06.

What is ETNB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ETNB) 89bio's current Earnings Per Share (EPS) is -$3.51. On average, analysts forecast that ETNB's EPS will be -$1.98 for 2025, with the lowest EPS forecast at -$2.33, and the highest EPS forecast at -$1.59. On average, analysts forecast that ETNB's EPS will be -$2.15 for 2026, with the lowest EPS forecast at -$2.50, and the highest EPS forecast at -$1.79. In 2027, ETNB's EPS is forecast to hit -$1.98 (min: -$2.75, max: -$1.42).

What is ETNB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ETNB) forecast ROE is -27.56%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.